cetylpyridinium chloride anhydrous has been researched along with Polycystic Ovary Syndrome in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Lam, YY; Wu, G; Zhang, C; Zhao, L; Zhao, N | 1 |
Doust, J; Jean Walker, M; Rogers, WA | 1 |
Mumford, SL; Plowden, T; Schisterman, EF; Schliep, KC; Sjaarda, LA; Wactawski-Wende, J; Yeung, E; Zarek, SM | 1 |
Arslanian, S; Tfayli, H | 1 |
Davies, MJ; March, WA; Marino, JL; Moore, VM; Willson, KJ | 1 |
Beltran, A; Bladé, C; Correig, X; Díaz, M; Ibañez, L; Mallol, R; Rodriguez, MA; Samino, S; Vinaixa, M; Yanes, O | 1 |
Birken, S; Gaughan, J; McChesney, R; Pettersson, K; Rechenberg, G; Taliadouros, G; Wu, CH; Yershova, O | 1 |
1 review(s) available for cetylpyridinium chloride anhydrous and Polycystic Ovary Syndrome
Article | Year |
---|---|
Menstrual health and the metabolic syndrome in adolescents.
Topics: Adolescent; Adult; Female; Health; Humans; Insulin Resistance; Menstruation; Metabolic Syndrome; Polycystic Ovary Syndrome; Risk Factors | 2008 |
1 trial(s) available for cetylpyridinium chloride anhydrous and Polycystic Ovary Syndrome
Article | Year |
---|---|
Metabolomics reveals reduction of metabolic oxidation in women with polycystic ovary syndrome after pioglitazone-flutamide-metformin polytherapy.
Topics: Abdominal Fat; Biomarkers; Carotid Intima-Media Thickness; Chromatography, Gas; Chromatography, Liquid; Dicarboxylic Acids; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Flutamide; Health; Humans; Linoleic Acid; Lipoproteins; Magnetic Resonance Spectroscopy; Metabolomics; Metformin; Multivariate Analysis; Oxidation-Reduction; Pioglitazone; Polycystic Ovary Syndrome; Spectrometry, Mass, Electrospray Ionization; Thiazolidinediones; Young Adult | 2011 |
5 other study(ies) available for cetylpyridinium chloride anhydrous and Polycystic Ovary Syndrome
Article | Year |
---|---|
Guild-based analysis for understanding gut microbiome in human health and diseases.
Topics: Databases, Genetic; Disease; Female; Gastrointestinal Microbiome; Health; Humans; Metagenomics; Obesity; Phylogeny; Polycystic Ovary Syndrome; RNA, Ribosomal, 16S | 2021 |
Current Dilemmas in Defining the Boundaries of Disease.
Topics: Biomarkers; Biostatistics; Diagnosis; Disease; Female; Health; Humans; Male; Medicalization; Myocardial Infarction; Philosophy, Medical; Polycystic Ovary Syndrome; Renal Insufficiency, Chronic | 2017 |
Dietary Carbohydrate Intake Does Not Impact Insulin Resistance or Androgens in Healthy, Eumenorrheic Women.
Topics: Adolescent; Adult; Androgens; Cohort Studies; Diet; Diet Records; Dietary Carbohydrates; Eating; Female; Health; Humans; Insulin Resistance; Menstrual Cycle; Polycystic Ovary Syndrome; Young Adult | 2015 |
Intergenerational associations of chronic disease and polycystic ovary syndrome.
Topics: Adult; Chronic Disease; Demography; Family Characteristics; Female; Health; Humans; Middle Aged; Polycystic Ovary Syndrome | 2011 |
Patterns of LHbetacf among women in health and disease.
Topics: Adult; Area Under Curve; Chorionic Gonadotropin, beta Subunit, Human; Female; Fertility; Health; Humans; Immunoassay; Luteinizing Hormone, beta Subunit; Menstrual Cycle; Mutation; Polycystic Ovary Syndrome; Postmenopause | 2007 |